Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 4 of 4 entries
Sorted by: Best Match Show Resources per page
Red Dress Day in Croatia: stroke prevention based on sex differences.

Croatian medical journal

Lovrenčić-Huzjan A, Poljaković Z.
PMID: 32118372
Croat Med J. 2020 Feb 29;61(1):5-7.

No abstract available.

Cite
Lovrenčić-Huzjan A, Poljaković Z. Red Dress Day in Croatia: stroke prevention based on sex differences. Croat Med J. 2020;61(1):5-7
Lovrenčić-Huzjan, A., & Poljaković, Z. (2020). Red Dress Day in Croatia: stroke prevention based on sex differences. Croatian medical journal, 61(1), 5-7.
Lovrenčić-Huzjan, Arijana, and Poljaković, Zdravka. "Red Dress Day in Croatia: stroke prevention based on sex differences." Croatian medical journal vol. 61,1 (2020): 5-7.
Lovrenčić-Huzjan A, Poljaković Z. Red Dress Day in Croatia: stroke prevention based on sex differences. Croat Med J. 2020 Feb 29;61(1):5-7. PMID: 32118372; PMCID: PMC7063547.
Copy Download .nbib Format: NLM
Evolution of Metastable Defects and Its Effect on the Electronic Properties of MoS.

Scientific reports

Precner M, Polaković T, Qiao Q, Trainer DJ, Putilov AV, Di Giorgio C, Cone I, Zhu Y, Xi XX, Iavarone M, Karapetrov G.
PMID: 29712931
Sci Rep. 2018 Apr 30;8(1):6724. doi: 10.1038/s41598-018-24913-y.

We report on structural and electronic properties of defects in chemical vapor-deposited monolayer and few-layer MoS

Cite
Precner M, Polaković T, Qiao Q, et al. Evolution of Metastable Defects and Its Effect on the Electronic Properties of MoS. Sci Rep. 2018;8(1):6724doi: 10.1038/s41598-018-24913-y.
Precner, M., Polaković, T., Qiao, Q., Trainer, D. J., Putilov, A. V., Di Giorgio, C., Cone, I., Zhu, Y., Xi, X. X., Iavarone, M., & Karapetrov, G. (2018). Evolution of Metastable Defects and Its Effect on the Electronic Properties of MoS. Scientific reports, 8(1), 6724. https://doi.org/10.1038/s41598-018-24913-y
Precner, M, et al. "Evolution of Metastable Defects and Its Effect on the Electronic Properties of MoS." Scientific reports vol. 8,1 (2018): 6724. doi: https://doi.org/10.1038/s41598-018-24913-y
Precner M, Polaković T, Qiao Q, Trainer DJ, Putilov AV, Di Giorgio C, Cone I, Zhu Y, Xi XX, Iavarone M, Karapetrov G. Evolution of Metastable Defects and Its Effect on the Electronic Properties of MoS. Sci Rep. 2018 Apr 30;8(1):6724. doi: 10.1038/s41598-018-24913-y. PMID: 29712931; PMCID: PMC5928116.
Copy Download .nbib Format: NLM
Moderating effect of ppar-γ on the association of c-reactive protein and ischemic stroke in patients younger than 60.

Gene

Bazina Martinović A, Merkler A, Ćelić I, Starčević K, Šimić M, Karmelić I, Poljaković Z, Kalinić D, Sertić J.
PMID: 34673211
Gene. 2022 Jan 30;809:146029. doi: 10.1016/j.gene.2021.146029. Epub 2021 Oct 18.

AIM: The aim of this study was to evaluate the moderating effect of peroxisome proliferator activated receptor-γ (PPAR-γ) gene variants on the association of serum C-reactive protein level (CRP) and ischemic stroke (IS).MATERIAL AND METHODS: A total of 114...

Cite
Bazina Martinović A, Merkler A, Ćelić I, et al. Moderating effect of ppar-γ on the association of c-reactive protein and ischemic stroke in patients younger than 60. Gene. 2021;809:146029doi: 10.1016/j.gene.2021.146029.
Bazina Martinović, A., Merkler, A., Ćelić, I., Starčević, K., Šimić, M., Karmelić, I., Poljaković, Z., Kalinić, D., & Sertić, J. (2022). Moderating effect of ppar-γ on the association of c-reactive protein and ischemic stroke in patients younger than 60. Gene, 809146029. https://doi.org/10.1016/j.gene.2021.146029
Bazina Martinović, A, et al. "Moderating effect of ppar-γ on the association of c-reactive protein and ischemic stroke in patients younger than 60." Gene vol. 809 (2022): 146029. doi: https://doi.org/10.1016/j.gene.2021.146029
Bazina Martinović A, Merkler A, Ćelić I, Starčević K, Šimić M, Karmelić I, Poljaković Z, Kalinić D, Sertić J. Moderating effect of ppar-γ on the association of c-reactive protein and ischemic stroke in patients younger than 60. Gene. 2022 Jan 30;809:146029. doi: 10.1016/j.gene.2021.146029. Epub 2021 Oct 18. PMID: 34673211.
Copy Download .nbib Format: NLM
Efficacy and safety of Cerebrolysin after futile recanalisation therapy in patients with severe stroke.

Clinical neurology and neurosurgery

Poljakovic Z, Supe S, Ljevak J, Starcevic K, Peric I, Blazevic N, Krbot-Skoric M, Jovanovic I, Ozretic D.
PMID: 34214867
Clin Neurol Neurosurg. 2021 Aug;207:106767. doi: 10.1016/j.clineuro.2021.106767. Epub 2021 Jun 18.

INTRODUCTION: Golden standard of acute stroke treatment is recanalisation therapy. However, opening the occluded blood vessel sometimes does not show the expected clinical result or leads to haemorrhagic complications. As neuroinflammation and neurotoxicity play an important role in the...

Cite
Poljakovic Z, Supe S, Ljevak J, et al. Efficacy and safety of Cerebrolysin after futile recanalisation therapy in patients with severe stroke. Clin Neurol Neurosurg. 2021;207:106767doi: 10.1016/j.clineuro.2021.106767.
Poljakovic, Z., Supe, S., Ljevak, J., Starcevic, K., Peric, I., Blazevic, N., Krbot-Skoric, M., Jovanovic, I., & Ozretic, D. (2021). Efficacy and safety of Cerebrolysin after futile recanalisation therapy in patients with severe stroke. Clinical neurology and neurosurgery, 207106767. https://doi.org/10.1016/j.clineuro.2021.106767
Poljakovic, Z, et al. "Efficacy and safety of Cerebrolysin after futile recanalisation therapy in patients with severe stroke." Clinical neurology and neurosurgery vol. 207 (2021): 106767. doi: https://doi.org/10.1016/j.clineuro.2021.106767
Poljakovic Z, Supe S, Ljevak J, Starcevic K, Peric I, Blazevic N, Krbot-Skoric M, Jovanovic I, Ozretic D. Efficacy and safety of Cerebrolysin after futile recanalisation therapy in patients with severe stroke. Clin Neurol Neurosurg. 2021 Aug;207:106767. doi: 10.1016/j.clineuro.2021.106767. Epub 2021 Jun 18. PMID: 34214867.
Copy Download .nbib Format: NLM
Showing 1 to 4 of 4 entries